Articles with public access mandates - Oskar HanssonLearn more
Not available anywhere: 33
Review
Biomarkers for neurodegenerative diseases
O Hansson
Nature medicine 27 (6), 954-963, 2021
Mandates: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Review
CSF and blood biomarkers for Parkinson's disease
L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ...
The Lancet Neurology 18 (6), 573-586, 2019
Mandates: Government of Italy
Review
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
H Kvartsberg, FH Duits, M Ingelsson, N Andreasen, A Öhrfelt, ...
Alzheimer's & Dementia 11 (10), 1180-1190, 2015
Mandates: Swedish Research Council
Review
CSF biomarkers predict a more malignant outcome in Alzheimer disease
AK Wallin, K Blennow, H Zetterberg, E Londos, L Minthon, O Hansson
Neurology 74 (19), 1531-1537, 2010
Mandates: Swedish Research Council
Review
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
S Linse, T Scheidt, K Bernfur, M Vendruscolo, CM Dobson, SIA Cohen, ...
Nature structural & molecular biology 27 (12), 1125-1133, 2020
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council, European …
Review
Apathy and anxiety are early markers of Alzheimer's disease
M Johansson, E Stomrud, O Lindberg, E Westman, PM Johansson, ...
Neurobiology of aging 85, 74-82, 2020
Mandates: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Review
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
N Mattsson, A Lönneborg, M Boccardi, K Blennow, O Hansson, ...
Neurobiology of aging 52, 196-213, 2017
Mandates: Swiss National Science Foundation, Swedish Research Council, European Commission
Review
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
J Daborg, U Andreasson, M Pekna, R Lautner, E Hanse, L Minthon, ...
Journal of Neural Transmission 119, 789-797, 2012
Mandates: Swedish Research Council
Review
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
M Holtta, L Minthon, O Hansson, J Holmén-Larsson, I Pike, M Ward, ...
Journal of proteome research 14 (2), 654-663, 2015
Mandates: Swedish Research Council
Review
Low IL‐8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels
S Janelidze, P Suchankova, A Ekman, S Erhardt, C Sellgren, ...
Acta Psychiatrica Scandinavica 131 (4), 269-278, 2015
Mandates: Swedish Research Council
Review
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
A Leuzy, NC Cullen, N Mattsson-Carlgren, O Hansson
Current opinion in neurology 34 (2), 266-274, 2021
Mandates: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Review
Association of enlarged perivascular spaces and measures of small vessel and Alzheimer disease
EC Gertje, D van Westen, C Panizo, N Mattsson-Carlgren, O Hansson
Neurology 96 (2), e193-e202, 2021
Mandates: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Review
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease
G Brinkmalm, A Brinkmalm, P Bourgeois, R Persson, O Hansson, ...
Brain research 1513, 117-126, 2013
Mandates: Swedish Research Council
Review
Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters
S Janelidze, F Ventorp, S Erhardt, O Hansson, L Minthon, J Flax, ...
Psychoneuroendocrinology 38 (6), 853-862, 2013
Mandates: Swedish Research Council
Review
Striatal changes in Parkinson disease: An investigation of morphology, functional connectivity and their relationship to clinical symptoms
C Owens-Walton, D Jakabek, X Li, FA Wilkes, M Walterfang, D Velakoulis, ...
Psychiatry Research: Neuroimaging 275, 5-13, 2018
Mandates: National Health and Medical Research Council, Australia, Swedish Research …
Review
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild …
K Buerger, O Uspenskaya, O Hartmann, O Hansson, L Minthon, ...
The Journal of clinical psychiatry 71 (4), 15017, 2010
Mandates: Science Foundation Ireland
Review
Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer’s disease patient with presenilin-1 mutation
R Smith, M Wibom, T Olsson, D Hägerström, J Jögi, GD Rabinovici, ...
Journal of Alzheimer's Disease 51 (2), 339-343, 2016
Mandates: Swedish Research Council, European Commission
Review
Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid immunotherapies
N Mattsson-Carlgren, LE Collij, E Stomrud, AP Binette, R Ossenkoppele, ...
JAMA neurology 81 (1), 69-78, 2024
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council
Review
Plasma NT1 tau is a specific and early marker of Alzheimer's disease
D Mengel, S Janelidze, RJ Glynn, W Liu, O Hansson, DM Walsh
Annals of Neurology 88 (5), 878-892, 2020
Mandates: German Research Foundation
Review
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
S Hall, S Janelidze, H Zetterberg, B Brix, N Mattsson, Y Surova, ...
Movement Disorders 35 (3), 513-518, 2020
Mandates: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Publication and funding information is determined automatically by a computer program